ArticleJNMA; journal of the Nepal Medical Association2021
Antibiotic Resistance to Escherichia coli among Urine Culture-Positive Patients in a Tertiary Care Hospital in Nepal: A Descriptive Cross-sectional Study.
Article in JNMA; journal of the Nepal Medical Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global prevalence of fluoroquinolone resistance inFrontiers in cellular and infection microbiology · 2026Pooled it
- Prevalence, antibiotic resistance pattern for bacteriuria from patients with urinary tract infections.Health science reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUrinary tract infection is treated by the antibiotic sensitivity pattern of uropathogens in our population. Present infection cases have been showing an increase in resistance to the current first-line of antibiotics. The objective of this study is to determine the resistance of antibiotics in Escherichia coli in a tertiary care center.
methodsThis is a descriptive cross-sectional study done in Kathmandu Medical College Teaching Hospital from October 2018 to February 2019. The sample size was calculated, and convenient sampling was done. Patients with urine culture positive (i.e., Colony-forming unit >105) were included in the study. All positive samples were tested for antibiotics sensitivity and resistance. The resistance to the antibiotics was recorded using Statistical Package for Social Sciences version 20. Point estimate at 95% confidence interval was calculated along with frequency and proportion for binary data.
resultsOut of 100 samples, the highest number of organisms isolated was Escherichia coli, 71 (71%). Escherichia coli showed the highest resistance to drugs like Norfloxacin, 37 (52.11%), AmoxicillinClavulanic acid 37 (52.11%), followed by Co-trimoxazole 32 (45.1%), Ceftriaxone, 24 (33.8%), and Ciprofloxacin 23 (32.3%).
conclusionsEscherichia coli showed the highest resistance to commonly used antibiotics like Norfloxacin, Amoxicillin-Clavulanic acid, Co-trimoxazole, Ceftriaxone, and Ciprofloxacin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.